The Patent Finder

Terms ending in 2041

Allergan, Inc.

Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,004,995Intraocular Implant with High Loading of a Prostamide
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 12,090,148Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 12,077,780Conditioned Medium from Cells Cultured Under Hypoxic Conditions and Uses Thereof
In force
 · High confidence
Allergan Sales, LLCIn forceHigh confidence
US 11,999,745Pharmaceutical Compounds
In force
 · High confidence
Nxera Pharma UK LimitedIn forceHigh confidence
US 11,717,515Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 11,857,542Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 12,070,450Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 12,194,030Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 12,329,750Treatment of Migraine
In force
 · Medium confidence
Allergan Pharmaceuticals International LimitedIn forceMedium confidence
9 of 9 patents shown. Soonest term end first, then patent number.
8 of these are in force and held by Allergan, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited